TREATMENT OF NF-kB-MEDIATED DISEASE

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20240299416A1
SERIAL NO

18655576

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure provides methods of treating or reducing the symptoms of muscular dystrophy in a human patient between the age of 1 day and 18 years old, comprising administering to the human patient in need thereof a therapeutically effective amount of a vamorolone and/or a salt thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
REVERAGEN BIOPHARMA INC3910 WARNER STREET KENSINGTON MD 20895

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
DAMSKER, Jesse Alexandria, US 17 45
HOFFMAN, Eric Rockville, US 73 1890

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation